New Eye Test Could Detect Early Signs of Alzheimer’s

By Being Patient | August 21st, 2019
Being Patient speaks to Professor Peter van Wijngaarden, the deputy director of the Centre for Eye Research in Australia (CERA), who is developing a “revolutionary” Alzheimer’s eye test that is entering a trial phase. The test has been funded by philanthropists like Bill Gates and applies imaging technology that is similar to what is used in used in NASA satellites.

If you find our articles and interviews helpful, please consider becoming a supporting member of our community. Frustrated by the lack of an editorially independent source of information on brain health and Alzheimer’s disease, we decided to create Being Patient. We are a team of dedicated journalists covering the latest research on Alzheimer’s, bringing you access to the experts and elevating the patient perspective on what it’s like to live with dementia.

Please help support our mission.

Peter van Wijngaarden

Professor Peter van Wijngaarden

Peter van Wijngaarden, MBBS, PhD, FRANZCO is a Principal Investigator at the Centre for Eye Research Australia (CERA) and an Associate Professor of Ophthalmology at the University of Melbourne Department of Surgery. He is a Deputy Director of CERA and an ophthalmologist in the medical retina clinic at the Royal Victorian Eye and Ear Hospital. Peter completed his PhD in the field of retinal vascular biology at Flinders University and his post-doctoral fellowship in regeneration of the central nervous system in multiple sclerosis, at the University of Cambridge, UK. Peter’s research is focused on novel imaging technologies to detect early markers of eye and central nervous system diseases, with a focus on Alzheimer’s disease. He is grateful for the support of the Yulgilbar Alzheimer’s Research Program, the Pratt Foundation, the H& L Hecht Trust, the Alzheimer’s Drug Discovery Foundation, the Sylvia and Charles Viertel Charitable Foundation, the Lord Mayor’s Charitable Foundation Eldon & Anne Foote Grant and the National Foundation for Medical Research and Innovation.

5 thoughts on “New Eye Test Could Detect Early Signs of Alzheimer’s

    1. No Liz. Dementia is brain failure. The most common single cause, accounting for about 60% of all cases, is Alzheimer’s. The most common early symptom of Alzheimer’s is short term memory loss.
      But the many other diseases and conditions causing dementia produce different early symptoms. The second most common cause of dementia is fronto-temporal lobar degeneration (“FTD”) for which the earliest symptoms are uninhibited behaviours or word-finding deficiencies.

Leave a Reply

We are glad you have chosen to leave a comment. Please keep in mind that comments are moderated according to our comment policy.